DEGUELIN, a novel anti-cancer agent, inhibits tumor aggressiveness and increases docetaxel efficacy in lung cancer cells

Basit Öğe Kaydı
dc.contributor.authorCengiz, H.
dc.contributor.authorKocdor, M. A.
dc.contributor.authorAydin, S.
dc.contributor.authorKocdor, H.
dc.date.accessioned2026-08-12T17:40:08Z
dc.date.issued2017
dc.departmentFırat Üniversitesi
dc.description42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back -- SEP 10-14, 2017 -- Jerusalem, ISRAEL
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipFederat European Biochem Soc
dc.identifier.endpage263
dc.identifier.issn1742-464X
dc.identifier.issn1742-4658
dc.identifier.startpage263
dc.identifier.urihttps://hdl.handle.net/11508/59141
dc.identifier.volume284
dc.identifier.wosWOS:000409918903191
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofFebs Journal
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.titleDEGUELIN, a novel anti-cancer agent, inhibits tumor aggressiveness and increases docetaxel efficacy in lung cancer cells
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu